Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
Provided By GlobeNewswire
Last update: Aug 18, 2025
SALT LAKE CITY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Ben Wheeler has been promoted to Chief Financial Officer, effective August 16, 2025.
Read more at globenewswire.com
